12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-14), Xilio Therapeutics's 12-1 Month Momentum % is -62.78%.
The industry rank for Xilio Therapeutics's 12-1 Month Momentum % or its related term are showing as below:
XLO's 12-1 Month Momentum % is ranked worse than 82.86% of 1488
companies
in the Biotechnology industry
Industry Median: -22.915
vs XLO: -62.78
Competitive Comparison of Xilio Therapeutics's 12-1 Month Momentum %
For the Biotechnology subindustry, Xilio Therapeutics's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xilio Therapeutics's 12-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xilio Therapeutics's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Xilio Therapeutics's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Xilio Therapeutics 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Xilio Therapeutics's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Xilio Therapeutics (Xilio Therapeutics) Business Description
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XLO has been successfully added to your